Strength training plus fasting regularly, and becoming diabetic!? No, it is just compensatory adaptation at work

One common outcome of doing glycogen-depleting exercise (e.g., strength training, sprinting) in combination with intermittent fasting is an increase in growth hormone (GH) levels. See this post for a graph showing the acute effect on GH levels of glycogen-depleting exercise. This effect applies to both men and women, and is generally healthy, leading to improvements in mood and many health markers.

It is a bit like GH therapy, with GH being “administered” to you by your own body. Both glycogen-depleting exercise and intermittent fasting increase GH levels; apparently they have an additive effect when done together.

Still, a complaint that one sees a lot from people who have been doing glycogen-depleting exercise and intermittent fasting for a while is that their fasting blood glucose levels go up. This is particularly true for obese folks (after they lose body fat), as obesity tends to be associated with low GH levels, although it is not restricted to the obese. In fact, many people decide to stop what they were doing because they think that they are becoming insulin resistant and on their way to developing type 2 diabetes. And, surely enough, when they stop, their blood glucose levels go down.

Guess what? If your blood glucose levels are going up quite a bit in response to glycogen-depleting exercise and intermittent fasting, maybe you are one of the lucky folks who are very effective at increasing their GH levels. The blood glucose increase effect is temporary, although it can last months, and is indeed caused by insulin resistance. An HbA1c test should also show an increase in hemoglobin glycation.

Over time, however, you will very likely become more insulin sensitive. What is happening is compensatory adaptation, with different short-term and long-term responses. In the short term, your body is trying to become a more efficient fat-burning machine, and GH is involved in this adaptation. But in the short term, GH leads to insulin resistance, probably via actions on muscle and fat cells. This gradually improves in the long term, possibly through a concomitant increase in liver insulin sensitivity and glycogen storage capacity.

This is somewhat similar to the response to GH therapy.

The figure below is from Johannsson et al. (1997). It shows what happened in terms of glucose metabolism when a group of obese men were administered recombinant GH for 9 months. The participants were aged 48–66, and were given in daily doses the equivalent to what would be needed to bring their GH levels to approximately what they were at age 20. For glucose, 5 mmol is about 90 mg, 5.5 is about 99, and 6 is about 108. GDR is glucose disposal rate; a measure of how quickly glucose is cleared from the blood.

As you can see, insulin sensitivity initially goes down for the GH group, and fasting blood glucose goes up quite a lot. But after 9 months the GH group has better insulin sensitivity. Their GDR is the same as in the placebo group, but with lower circulating insulin. The folks in the GH group also have significantly less body fat, and have better health markers, than those who took the placebo.

There is such a thing as sudden-onset type 2-like diabetes, but it is very rare (see Michael’s blog). Usually type 2 diabetes “telegraphs” its arrival through gradually increasing fasting blood glucose and HbA1c. However, those normally come together with other things, notably a decrease in HDL cholesterol and an increase in fasting triglycerides. Folks who do glycogen-depleting exercise and intermittent fasting tend to see the opposite – an increase in HDL cholesterol and a decrease in triglycerides.

So, if you are doing things that have the potential to increase your GH levels, a standard lipid panel can help you try to figure out whether insulin resistance is benign or not, if it happens.

By the way, GH and cortisol levels are correlated, which is often why some associate responses to glycogen-depleting exercise and intermittent fasting with esoteric nonsense that has no basis in scientific research like “adrenal fatigue”. Cortisol levels are meant to go up and down, but they should not go up and stay up while you are sitting down.

Avoid chronic stress, and keep on doing glycogen-depleting exercise and intermittent fasting; there is overwhelming scientific evidence that these things are good for you.

Blood glucose levels in birds are high yet HbA1c levels are low: Can vitamin C have anything to do with this?

Blood glucose levels in birds are often 2-4 times higher than those in mammals of comparable size. Yet birds often live 3 times longer than mammals of comparable size. This is paradoxical. High glucose levels are generally associated with accelerated senescence, but birds seem to age much slower than mammals. Several explanations have been proposed for this, one of which is related to the formation of advanced glycation endproducts (AGEs).

Glycation is a process whereby sugar molecules “stick” to protein or fat molecules, impairing their function. Glycation leads to the formation of AGEs, which seem to be associated with a host of diseases, including diabetes, and to be implicated in accelerated aging (or “ageing”, with British spelling).

The graphs below, from Beuchat & Chong (1998), show the glucose levels (at rest and prior to feeding) and HbA1c levels (percentage of glycated hemoglobin) in birds and mammals. HbA1c is a measure of the degree of glycation of hemoglobin, a protein found in red blood cells. As such HbA1c (given in percentages) is a good indicator of the rate of AGE formation within an animal’s body.

The glucose levels are measured in mmol/l; they should be multiplied by 18 to obtain the respective measures in mg/dl. For example, the 18 mmol/l glucose level for the Anna’s (a hummingbird species) is equivalent to 324 mg/dl. Even at that high level, well above the level of a diabetic human, the Anna’s hummingbird species has an HbA1c of less than 5, which is lower than that for most insulin sensitive humans.

How can that be?

There are a few possible reasons. Birds seem to have evolved better mechanisms to control cell permeability to glucose, allowing glucose to enter cells very selectively. Birds also seem to have a higher turnover of cells where glycation and thus AGE formation results. The lifespan of red blood cells in birds, for example, is only 50 to 70 percent that of mammals.

But one of the most interesting mechanisms is vitamin C synthesis. Not only is vitamin C a powerful antioxidant, but it also has the ability to reversibly bind to proteins at the sites where glycation would occur. That is, vitamin C has the potential to significantly reduce glycation. The vast majority of birds and mammals can synthesize vitamin C. Humans are an exception. They have to get it from their diet.

This may be one of the many reasons why isolated human groups with traditional diets high in fruits and starchy tubers, which lead to temporary blood glucose elevations, tend to have good health. Fruits and starchy tubers in general are good sources of vitamin C.

Grains and seeds are not.

References

Beuchat, C.A., & Chong, C.R. (1998). Hyperglycemia in hummingbirds and its consequences for hemoglobin glycation. Comparative Biochemistry and Physiology Part A, 120(3), 409–416.

Holmes D.J., Flückiger, R., & Austad, S.N. (2001). Comparative biology of aging in birds: An update. Experimental Gerontology, 36(4), 869-883.

Postprandial glucose levels, HbA1c, and arterial stiffness: Compared to glucose, lipids are not even on the radar screen

Postprandial glucose levels are the levels of blood glucose after meals. In Western urban environments, the main contributors to elevated postprandial glucose are foods rich in refined carbohydrates and sugars. While postprandial glucose levels may vary somewhat erratically, they are particularly elevated in the morning after breakfast. The main reason for this is that breakfast, in Western urban environments, is typically very high in refined carbohydrates and sugars.

HbA1c, or glycated hemoglobin, is a measure of average blood glucose over a period of a few months. Blood glucose glycates (i.e., sticks to) hemoglobin, a protein found in red blood cells. Red blood cells are relatively long-lived, lasting approximately 3 months. Thus HbA1c (given in percentages) is a good indicator of average blood glucose levels, if you don’t suffer from anemia or a few other blood abnormalities.

Based on HbA1c, one can then estimate his or her average blood glucose level for the previous 3 months or so before the test, using one of the following equations, depending on whether the measurement is in mg/dl or mmol/l.

Average blood glucose (mg/dl) = 28.7 × HbA1c − 46.7
Average blood glucose (mmol/l) = 1.59 × HbA1c − 2.59

Elevated blood glucose levels cause damage in the body primarily through glycation, which leads to the formation of advanced glycation endproducts (AGEs). Given this, HbA1c can be seen as a proxy for the level of damage done by elevated blood glucose levels to various body tissues. This damage occurs over time; often after many years of high blood glucose levels. It includes kidney damage, neurological damage, cardiovascular damage, and damage to the retina.

Most regular blood exams focus on fasting blood glucose as a measure of glucose metabolism status. Many medical practitioners have as a target a fasting blood glucose level of 125 mg/dl (7 mmol/l) or less, and largely disregard postprandial glucose levels or HbA1c in their management of glucose metabolism. Leiter and colleagues (2005; full reference at the end of this post) showed that this focus on fasting blood glucose is a mistake. They are not alone; many others made this point, including some very knowledgeable bloggers who focus on diabetes (see “Interesting links” section of this blog). Leiter and colleagues (2005) also provided some interesting graphs and figures, including eye-opening correlations between various variables and arterial stiffness. The figure below (click to enlarge) shows the contribution of postprandial glucose to HbA1c.

Note that the lower the HbA1c is in the figure (horizontal axis), the higher is the postprandial glucose contribution to HbA1c. And, the lower the HbA1c, the closer the individuals are to what one could consider having a perfectly normal HbA1c level (around 5 percent). That is, only for individuals whose HbA1c levels are very high, fasting blood glucose levels are relatively reliable measures of the tissue damage done be elevated blood glucose levels.

The table below (click to enlarge) shows P values associated with the impact of various variables (listed on the leftmost column) on arterial stiffness. This measure, arterial stiffness, is strongly associated with an increased risk of cardiovascular events. Look at the middle column showing P values adjusted for age and height. The lower the P value, the more a variable affects arterial stiffness. The variable with the lowest P value by far is 2-hour postprandial blood glucose; the blood glucose levels measured 2 hours after meals.

Fasting glucose levels were reported to be statistically insignificant because of the P = 0.049, in terms of their effect on arterial stiffness, but this P value is actually significant, although barely, at the 0.05 level (95 percent confidence). Interestingly, the following measures are not even on the radar screen, as far as arterial stiffness is concerned: systolic blood pressure, LDL cholesterol, HDL cholesterol, triglycerides, and fasting insulin levels.

What about the lipid hypothesis, and the “bad” LDL cholesterol!? This study is telling us that these are not very relevant for arterial stiffness when we control for the effect of blood glucose measures. Not even fasting insulin levels matters much! Wait, not even HDL!!! A high HDL has been definitely shown to be protective, but when we look at the relative magnitude of various effects, the story is a bit different. A high HDL’s protective effect exists, but it is dwarfed by the negative effect of high blood glucose levels, especially after meals, in the context of cardiovascular disease.

What all this points at is what we could call a postprandial glucose hypothesis: Lower your postprandial glucose levels, and live a longer, healthier life! And, by the way, if your postprandial glucose levels are under control, lipids do not matter much! Or maybe your lipids will fall into place, without any need for statin drugs, after your postprandial glucose levels are under control. One way or another, the outcome will be a positive one. That is what the data from this study is telling us.

How do you lower your postprandial glucose levels?

A good way to start is to remove foods rich in refined carbohydrates and sugars from your diet. Almost all of these are foods engineered by humans with the goal of being addictive; they usually come in boxes and brightly colored plastic wraps. They are not hard to miss. They are typically in the central aisles of supermarkets. The sooner you remove them from your diet, the better. The more completely you do this, the better.

Note that the evidence discussed in this post is in connection with blood glucose levels, not glucose metabolism per se. If you have impaired glucose metabolism (e.g., diabetes type 2), you can still avoid a lot of problems if you effectively control your blood glucose levels. You may have to be a bit more aggressive, adding low carbohydrate dieting (as in the Atkins or Optimal diets) to the removal of refined carbohydrates and sugars from your diet; the latter is in many ways similar to adopting a Paleolithic diet. You may have to take some drugs, such as Metformin (a.k.a. Glucophage). But you are certainly not doomed if you are diabetic.

Reference:

Leiter, L.A., Ceriello, A., Davidson, J.A., Hanefeld, M., Monnier, L., Owens, D.R., Tajima, N., & Tuomilehto, J. (2005). Postprandial glucose regulation: New data and new implications. Clinical Therapeutics, 27(2), S42-S56.

Blood glucose control before age 55 may increase your chances of living beyond 90

I have recently read an interesting study by Yashin and colleagues (2009) at Duke University’s Center for Population Health and Aging. (The full reference to the article, and a link, are at the end of this post.) This study is a gem with some rough edges, and some interesting implications.

The study uses data from the Framingham Heart Study (FHS). The FHS, which started in the late 1940s, recruited 5209 healthy participants (2336 males and 2873 females), aged 28 to 62, in the town of Framingham, Massachusetts. At the time of Yashin and colleagues’ article publication, there were 993 surviving participants.

I rearranged figure 2 from the Yashin and colleagues article so that the two graphs (for females and males) appeared one beside the other. The result is shown below (click on it to enlarge); the caption at the bottom-right corner refers to both graphs. The figure shows the age-related trajectory of blood glucose levels, grouped by lifespan (LS), starting at age 40.

As you can see from the figure above, blood glucose levels increase with age, even for long-lived individuals (LS > 90). The increases follow a U-curve (a.k.a. J-curve) pattern; the beginning of the right side of a U curve, to be more precise. The main difference in the trajectories of the blood glucose levels is that as lifespan increases, so does the width of the U curve. In other words, in long-lived people, blood glucose increases slowly with age; particularly up to 55 years of age, when it starts increasing more rapidly.

Now, here is one of the rough edges of this study. The authors do not provide standard deviations. You can ignore the error bars around the points on the graph; they are not standard deviations. They are standard errors, which are much lower than the corresponding standard deviations. Standard errors are calculated by dividing the standard deviations by the square root of the sample sizes for each trajectory point (which the authors do not provide either), so they go up with age since progressively smaller numbers of individuals reach advanced ages.

So, no need to worry if your blood glucose levels are higher than those shown on the vertical axes of the graphs. (I will comment more on those numbers below.) Not everybody who lived beyond 90 had a blood glucose of around 80 mg/dl at age 40. I wouldn't be surprised if about 2/3 of the long-lived participants had blood glucose levels in the range of 65 to 95 at that age.

Here is another rough edge. It is pretty clear that the authors’ main independent variable (i.e., health predictor) in this study is average blood glucose, which they refer to simply as “blood glucose”. However, the measure of blood glucose in the FHS is a very rough estimation of average blood glucose, because they measured blood glucose levels at random times during the day. These measurements, when averaged, are closer to fasting blood glucose levels than to average blood glucose levels.

A more reliable measure of average blood glucose levels is that of glycated hemoglobin (HbA1c). Blood glucose glycates (i.e., sticks to, like most sugary substances) hemoglobin, a protein found in red blood cells. Since red blood cells are relatively long-lived, with a turnover of about 3 months, HbA1c (given in percentages) is a good indicator of average blood glucose levels (if you don’t suffer from anemia or a few other blood abnormalities). Based on HbA1c, one can then estimate his or her average blood glucose level for the previous 3 months before the test, using one of the following equations, depending on whether the measurement is in mg/dl or mmol/l.

    Average blood glucose (mg/dl) = 28.7 × HbA1c − 46.7

    Average blood glucose (mmol/l) = 1.59 × HbA1c − 2.59

The table below, from Wikipedia, shows average blood glucose levels corresponding to various HbA1c values. As you can see, they are generally higher than the corresponding fasting blood glucose levels would normally be (the latter is what the values on the vertical axes of the graphs above from Yashin and colleagues’ study roughly measure). This is to be expected, because blood glucose levels vary a lot during the day, and are often transitorily high in response to food intake and fluctuations in various hormones. Growth hormone, cortisol and noradrenaline are examples of hormones that increase blood glucose. Only one hormone effectively decreases blood glucose levels, insulin, by stimulating glucose uptake and storage as glycogen and fat.

Nevertheless, one can reasonably expect fasting blood glucose levels to have been highly correlated with average blood glucose levels in the sample. So, in my opinion, the graphs above showing age-related blood glucose trajectories are still valid, in terms of their overall shape, but the values on the vertical axes should have been measured differently, perhaps using the formulas above.

Ironically, those who achieve low average blood glucose levels (measured based on HbA1c) by adopting a low carbohydrate diet (one of the most effective ways) frequently have somewhat high fasting blood glucose levels because of physiological (or benign) insulin resistance. Their body is primed to burn fat for energy, not glucose. Thus when growth hormone levels spike in the morning, so do blood glucose levels, as muscle cells are in glucose rejection mode. This is a benign version of the dawn effect (a.k.a. dawn phenomenon), which happens with quite a few low carbohydrate dieters, particularly with those who are deep in ketosis at dawn.

Yashin and colleagues also modeled relative risk of death based on blood glucose levels, using a fairly sophisticated mathematical model that takes into consideration U-curve relationships. What they found is intuitively appealing, and is illustrated by the two graphs at the bottom of the figure below. The graphs show how the relative risks (e.g., 1.05, on the topmost dashed line on the both graphs) associated with various ranges of blood glucose levels vary with age, for both females and males.

What the graphs above are telling us is that once you reach old age, controlling for blood sugar levels is not as effective as doing it earlier, because you are more likely to die from what the authors refer to as “other causes”. For example, at the age of 90, having a blood glucose of 150 mg/dl (corrected for the measurement problem noted earlier, this would be perhaps 165 mg/dl, from HbA1c values) is likely to increase your risk of death by only 5 percent. The graphs account for the facts that: (a) blood glucose levels naturally increase with age, and (b) fewer people survive as age progresses. So having that level of blood glucose at age 60 would significantly increase relative risk of death at that age; this is not shown on the graph, but can be inferred.

Here is a final rough edge of this study. From what I could gather from the underlying equations, the relative risks shown above do not account for the effect of high blood glucose levels earlier in life on relative risk of death later in life. This is a problem, even though it does not completely invalidate the conclusion above. As noted by several people (including Gary Taubes in his book Good Calories, Bad Calories), many of the diseases associated with high blood sugar levels (e.g., cancer) often take as much as 20 years of high blood sugar levels to develop. So the relative risks shown above underestimate the effect of high blood glucose levels earlier in life.

Do the long-lived participants have some natural protection against accelerated increases in blood sugar levels, or was it their diet and lifestyle that protected them? This question cannot be answered based on the study.

Assuming that their diet and lifestyle protected them, it is reasonable to argue that: (a) if you start controlling your average blood sugar levels well before you reach the age of 55, you may significantly increase your chances of living beyond the age of 90; (b) it is likely that your blood glucose levels will go up with age, but if you can manage to slow down that progression, you will increase your chances of living a longer and healthier life; (c) you should focus your control on reliable measures of average blood glucose levels, such as HbA1c, not fasting blood glucose levels (postprandial glucose levels are also a good option, because they contribute a lot to HbA1c increases); and (d) it is never too late to start controlling your blood glucose levels, but the more you wait, the bigger is the risk.

References:

Taubes, G. (2007). Good calories, bad calories: Challenging the conventional wisdom on diet, weight control, and disease. New York, NY: Alfred A. Knopf.

Yashin, A.I., Ukraintseva, S.V., Arbeev, K.G., Akushevich, I., Arbeeva, L.S., & Kulminski, A.M. (2009). Maintaining physiological state for exceptional survival: What is the normal level of blood glucose and does it change with age? Mechanisms of Ageing and Development, 130(9), 611-618.